Contrast enhanced lung MRI in mice using ultra-short echo time radial imaging and intratracheally administrated Gd-DOTA-based nanoparticles

Magnetic Resonance in Medicine

Volumn 70, Issue 5, 2013, Pages 1419-1426

  Bianchi, Andrea ^a   Lux, François ^b   Tillement, Olivier ^b   Crémillieux, Yannick ^a  

^a CENTRE DE RECHERCHE CARDIO THORACIQUE DE BORDEAUX   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

contrast agent; gadolinium; lung proton MRI; nanoparticles; UTE

Indexed keywords

BLOOD; CONTRAST MEDIA; DRUG DELIVERY; GADOLINIUM; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MAMMALS; NANOPARTICLES; TISSUE;

CONTRAST AGENT; CONTRAST-ENHANCED; DISEASED TISSUES; FUTURE APPLICATIONS; INTRATRACHEAL INSTILLATION; PROTON MRIS; SIGNAL ENHANCEMENT; ULTRASHORT ECHO TIME;

BIOLOGICAL ORGANS;

GADOTERIC ACID; NANOPARTICLE;

AEROSOL; ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION RESPONSE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG ELIMINATION; FEASIBILITY STUDY; FEMALE; IMAGE RECONSTRUCTION; IN VIVO STUDY; LUNG PARENCHYMA; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; SIGNAL NOISE RATIO;

CONTRAST AGENT; GADOLINIUM; LUNG PROTON MRI; NANOPARTICLES; UTE;

ALGORITHMS; ANIMALS; CONTRAST MEDIA; FEMALE; HETEROCYCLIC COMPOUNDS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LUNG; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED BALB C; NANOPARTICLES; ORGANOMETALLIC COMPOUNDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84886768186     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.24580     Document Type: Article

References (29)

1. Berthezène Y, Vexler V, Clément O, Mühler A, Moseley ME, Brasch RC,. Contrast-enhanced MR imaging of the lung: assessments of ventilation and perfusion. Radiology 1992; 183: 667-672.
2. Berthezène Y, Mulher A, Lang P, Shames D, Clement O, Rosenay W, Kuwatsuru R, Brasch R,. Safety aspects and pharmacokinetics of inhaled aerosolized Gadolinium. J Magn Reson Imaging 1993; 3: 125-130.
3. Haage P, Karaagac S, Adam G, Glowinski A, Günther RW,. Comparison of aerosolized gadoteridol and gadopentetate dimeglumine for magnetic resonance ventilation imaging of the lung. Magn Reson Med 2001; 46: 803-806.
4. Suga K, Yuan Y, Nobuhiko O, Okada M, Kawakami Y, Matsunaga N,. Potential of magnetic resonance lymphography with intrapulmonary injection of gadopentetate dimeglumine for visualization of the pulmonary lymphatic basin in dogs: preliminary results. Invest Radiol 2003; 38: 679-689.
5. Sood BG, Shen Y, Latif Z, Chen X, Sharp J, Neelavalli J, Joshi A, Slovis TL, Haacke EM,. Aerosol delivery in ventilated newborn pigs: an MRI evaluation. Pediatr Res 2008; 64: 159-164.
6. Mosbah K, Ruiz-Cabello J, Berthezène Y, Crémillieux Y,. Aerosols and gaseous contrast agents for magnetic resonance imaging of the lung. Contrast Media Mol Imaging 2008; 3: 173-190.
7. Bergin CJ, Pauly JM, Macovski A,. Lung parenchyma: projection reconstruction MR imaging. Radiology 1991; 179: 777-781.
8. Bergin CJ, Noll DC, Pauly JM, Glover GH, Macovski A,. MRI imaging of lung parenchyma: a solution to susceptibility. Radiology 1992; 183: 673-676.
9. Gewalt SL, Glover GH, Hedlund LW, Cofer GP, MacFall JR, Johnson GA,. MR microscopy of the rat lung using projection recostruction. Magn Reson Med 1993; 29: 99-106.
10. Johnson GA, Cofer GP, Hedlund LW, Maronpot RR, Suddarth SA,. Registered 1H and 3He magnetic resonance microscopy of the lung. Magn Reson Med 2001; 45: 365-370.
11. Zurek M, Bessaad A, Cieslar K, Crémillieux Y,. Validation of simple and robust protocols for high-resolution lung proton MRI in mice. Magn Reson Med 2010; 64: 401-407.
12. Lewin M, Carlesso N, Tung CH, Tang XW, Cory D, Scadden DT, Weissleder R,. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 2000; 18: 410-414.
13. Lux F, Mignot A, Mowat P, et al. Ultrasmall rigid particles as multimodal probes for medical applications. Angew Chem 2011; 123: 12507-12511.
14. Kim JS, Kim YH, Kim JH, et al. Development and in vivo imaging of a PET/MRI nanoprobe with enhanced NIR fluorescence by dye encapsulation. Nanomedicine 2012; 7: 219-229.
15. Alric C, Taleb J, Le Duc G, et al. Gadolinium chelate coated gold nanoparticles as contrast agents for both X-ray computed tomography and magnetic resonance imaging. J Am Chem Soc 2008; 130: 5908-5915.
16. 3 in mice using multivalent or monovalent cRGD targeting vectors. Mol Cancer 2007; 6: 41.
17. Le Duc G, Miladi I, Alric C, et al. Toward an image-guided microbeam radiation therapy using gadolinium-based nanoparticles. ACS Nano 2011; 5: 9566-9574.
18. Benezra M, Penate-Medina O, Zanzonico PB, et al. Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma. J Clin Invest 2011; 121: 2768-2780.
19. Driscoll KE, Costa DL, Hatch G, Henderson R, Oberdorster G, Salem H, Schlesinger RB,. Intratracheal instillation as an exposure technique for the evaluation of respiratory tract toxicity: uses and limitations. Toxicol Sci 2000; 55: 24-35.
20. Costa DL, Lehmann JR, Winsett D, Richards J, Ledbetter AD, Dreher KL,. Comparative pulmonary toxicological assessment of oil combustion particles following inhalation or instillation exposure. Toxicol Sci 2006; 91: 237-246.
21. Shoyele SA, Cawthome S,. Particle engineering techniques for inhaled biopharmaceuticals. Adv Drug Deliv Rev 2006; 58: 1009-1029.
22. Jackson JI, Meyer CH, Nishimura DG, Macovski A,. Selection of a convolution function for Fourier inversion using gridding. IEEE Trans Med Imaging 1991; 10: 473-478.
23. Armitage P, Behrenbruch C, Brady M, Moore N,. Extracting and visualizing physiological parameters using dynamic contrast-enhanced magnetic resonance imaging of the breast. Med Image Anal 2005; 9: 315-329.
24. Glover GH, Pauly JM,. Projection reconstruction techniques for reduction of motion effects in MRI. Magn Reson Med 1992; 28: 275-289.
25. Choi HS, Ashitate Y, Lee JH, et al. Rapid translocation of nanoparticles from the lung airspaces to the body. Nat Biotech 2010; 28: 1300-1303.
26. Choi HS, Liu W, Liu F, Nasr K, Misra P, Bawendi MG, Frangioni JV,. Design considerations for tumour-targeted nanoparticles. Nat Nano 2010; 5: 42-47.
27. Silvennoinen MJ, Kettunen MI, Kauppinen RA,. Effects of hematocrit and oxygen saturation level on blood spin-lattice relaxation. Magn Reson Med 2003; 49: 568-571.
28. Roa WH, Azarmi S, Al-Hallak MK, Finlay WH, Magliocco AM, Löbenberg R,. Inhalable nanoparticles, a non-invasive approach to treat lung cancer in a mouse model. J Control Release 2011; 150: 49-55.
29. Choi HS, Liu W, Misra P, Tanaka E, Zimmer JP, Itty Ipe B, Bawendi MG, Frangioni JV,. Renal clearance of nanoparticles. Nat Biotech 2007; 25: 1165-1170.